NDC properties for "adalimumab-ryvk 40 MG per 0.4 ML Auto-Injector" (RxCUI 2677780)
About this data
The tables show NDC propoerties for adalimumab-ryvk 40 MG per 0.4 ML Auto-Injector with the RxCUI 2677780
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-ryvk 40 MG per 0.4 ML Auto-Injector (RxCUI 2677780)
| BLA | BLA761299 |
|---|---|
| MMSL_CODE | BD40449 |
| RxCUI | 2677780 |
| SPL_SET_ID | 2d19a877-1f5a-4731-800a-dddadc424080 |
| SPL_SET_ID | dce1590f-9e47-4c4d-9437-cfb18b779a75 |
| VUID | 4043043 |
| Prescribable Synonym | adalimumab-ryvk 40 MG in 0.4 ML Auto-Injector |
| RXNAV_STR | 0.4 ML adalimumab-ryvk 100 MG/ML Auto-Injector |
| RxNorm Name | 0.4 ML adalimumab-ryvk 100 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-ryvk 40 MG per 0.4 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2677780) |
NDC Properties
NDC Item 51759036002
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-02 |
| NDC Item | 51759036002 |
| Packaging | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 51759036017
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-17 |
| NDC Item | 51759036017 |
| Packaging | 1 KIT in 1 CARTON (51759-360-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 82009015622
| NDC 9 | 82009-156 |
|---|---|
| NDC 10 | 82009-156-22 |
| NDC Item | 82009015622 |
| Packaging | 2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-156 |
NDC Item 82009015711
| NDC 9 | 82009-157 |
|---|---|
| NDC 10 | 82009-157-11 |
| NDC Item | 82009015711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-157 |
NDC Item 51759036002
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-02 |
| NDC Item | 51759036002 |
| Packaging | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 51759036017
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-17 |
| NDC Item | 51759036017 |
| Packaging | 1 KIT in 1 CARTON (51759-360-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 82009015622
| NDC 9 | 82009-156 |
|---|---|
| NDC 10 | 82009-156-22 |
| NDC Item | 82009015622 |
| Packaging | 2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-156 |
NDC Item 82009015711
| NDC 9 | 82009-157 |
|---|---|
| NDC 10 | 82009-157-11 |
| NDC Item | 82009015711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-157 |
NDC Item 51759036002
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-02 |
| NDC Item | 51759036002 |
| Packaging | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 51759036017
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-17 |
| NDC Item | 51759036017 |
| Packaging | 1 KIT in 1 CARTON (51759-360-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 82009015622
| NDC 9 | 82009-156 |
|---|---|
| NDC 10 | 82009-156-22 |
| NDC Item | 82009015622 |
| Packaging | 2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-156 |
NDC Item 82009015711
| NDC 9 | 82009-157 |
|---|---|
| NDC 10 | 82009-157-11 |
| NDC Item | 82009015711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-157 |
NDC Item 51759036002
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-02 |
| NDC Item | 51759036002 |
| Packaging | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 51759036017
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-17 |
| NDC Item | 51759036017 |
| Packaging | 1 KIT in 1 CARTON (51759-360-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-360 |
NDC Item 82009015622
| NDC 9 | 82009-156 |
|---|---|
| NDC 10 | 82009-156-22 |
| NDC Item | 82009015622 |
| Packaging | 2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-156 |
NDC Item 82009015711
| NDC 9 | 82009-157 |
|---|---|
| NDC 10 | 82009-157-11 |
| NDC Item | 82009015711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-157 |